AQR Arbitrage’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-895,333
Closed -$22.3M – 711
2026
Q2
$22.3M Buy
+895,333
New +$21M 0.32% 64
2017
Q1
– Sell
-168,421
Closed -$6.23M – 340
2016
Q4
$6.23M Sell
168,421
-233,700
-58% -$8.35M 0.06% 172
2016
Q3
$13.9M Sell
402,121
-107,595
-21% -$3.77M 0.14% 142
2016
Q2
$16.6M Hold
509,716
– – 0.18% 126
2016
Q1
$14.6M Buy
509,716
+258,743
+103% +$6.89M 0.17% 125
2015
Q4
$8.38M Buy
+250,973
New +$7.8M 0.09% 161

Other funds holding AVNS

AQR Arbitrage's AVNS Position: Q3 2026 in Review

AQR Arbitrage sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 895,333 shares — an estimated $22.3M sold.

AQR Arbitrage first reported a position in AVNS in Q4 2015 and held it in 6 quarters. The position peaked at $22.3M in Q2 2026. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

  • AQR Arbitrage reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
  • AQR Arbitrage sold 895,333 Avanos Medical shares in Q3 2026, an estimated $22.3M.
  • AQR Arbitrage first reported a position in Avanos Medical in Q4 2015 and held it in 6 quarters.
  • AQR Arbitrage's Avanos Medical position peaked at $22.3M in Q2 2026.
  • 3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on AQR Arbitrage's 13F filing for Q3 2026, filed 16 Nov 2026.